Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Urinary Catheters

Sponsor
Region Skane (Other)
Overall Status
Completed
CT.gov ID
NCT03289117
Collaborator
Lund University (Other), Vinnova (Other), Innovation Skåne AB/ Sweden (Other)
32
1
2
13.3
2.4

Study Details

Study Description

Brief Summary

A randomized, open label, controlled, parallel group study to investigate difference between regional standard procedure and a novel modified procedure (using an additional novel device to facilitate gel installation) for changing long-term indwelling urinary catheters.

Condition or Disease Intervention/Treatment Phase
  • Device: Novel gel installation device procedure
  • Device: Standard procedure
N/A

Detailed Description

This is a randomized, open label, controlled, parallel group study, which comprises one visit that includes: assessment for eligibility, randomization to one of two treatment alternatives, followed by the actual intervention and evaluation of outcomes.

The interventions are either change of catheter according to the regional standard procedure (the comparator group) or change of catheter with the additional use of the novel device to facilitate gel instillation and a slightly modified procedure (the experimental group).

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Arm 1: Experimental: Novel device: Assigned Interventions: Catheter change with novel device. Each subject will undergo catheter change with novel gel instillation device. Arm 2: Comparator: Standard procedure: Assigned Interventions: Catheter change with standard procedure. Each subject will undergo catheter change with standard procedure.Arm 1: Experimental: Novel device: Assigned Interventions: Catheter change with novel device. Each subject will undergo catheter change with novel gel instillation device. Arm 2: Comparator: Standard procedure: Assigned Interventions: Catheter change with standard procedure. Each subject will undergo catheter change with standard procedure.
Masking:
Single (Outcomes Assessor)
Masking Description:
Open label
Primary Purpose:
Supportive Care
Official Title:
Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Indwelling Urinary Catheters - a Randomized Controlled Study
Actual Study Start Date :
Apr 17, 2016
Actual Primary Completion Date :
May 26, 2017
Actual Study Completion Date :
May 26, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Novel gel installation device procedure

Catheter change with novel device. Each subject will undergo catheter change with novel gel instillation device procedure

Device: Novel gel installation device procedure
Catheter change with novel device Each subject will undergo catheter change with novel gel instillation device

Active Comparator: Standard procedure

Catheter change with standard procedure. Each subject will undergo catheter change with standard procedure

Device: Standard procedure
Catheter change with standard procedure Each subject will undergo catheter change with standard procedure

Outcome Measures

Primary Outcome Measures

  1. Treatment duration (min) [During procedure]

    Treatment duration for procedure

Secondary Outcome Measures

  1. Patient's perceived pain (NRS scale) [During intervention]

    Patient's perceived pain estimated by patient using a numerical rating scale (NRS-scale)

  2. Number of gel syringes used [During intervention]

    Number of pre-filled gel syringes used during the procedure

Other Outcome Measures

  1. Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] [During intervention]

    Incidence of Treatment-Emergent Adverse Events found during procedure

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • The patient has an indwelling catheter and a primary diagnosis that justify continued catheter use

  • The patient provides informed consent prior to any study specific procedures

  • The patient is considered to benefit from participation in the clinical study

Exclusion Criteria:
  • The patient do not consent to participate in the study

  • Trauma to urethra or bladder

  • Infection to urethra or bladder

  • Other diagnosis that contraindicates participation in the clinical study as judged by the responsible physician

Contacts and Locations

Locations

Site City State Country Postal Code
1 Skåne University Hospital - Urology clinic - Homecare unit Lund Sweden 22185

Sponsors and Collaborators

  • Region Skane
  • Lund University
  • Vinnova
  • Innovation Skåne AB/ Sweden

Investigators

  • Principal Investigator: Ulf Malmqvist, PhD, Clinical Studies Sweden - Forum South

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Region Skane
ClinicalTrials.gov Identifier:
NCT03289117
Other Study ID Numbers:
  • 2016 02 01 ver 1_1
First Posted:
Sep 20, 2017
Last Update Posted:
Oct 20, 2017
Last Verified:
Oct 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Region Skane
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 20, 2017